AXA Framlington Biotech Fund - R IncomeRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Price Return | 8.55 | -7.34 | 18.15 | 31.42 | 2.35 | 3.02 | 1.09 | 4.32 |
+/- Category | -1.75 | 0.62 | -2.05 | 5.45 | 11.38 | 10.85 | 2.37 | 2.02 |
+/- Category Index | -6.64 | -5.49 | 1.44 | -1.51 | 2.05 | 0.55 | -6.24 | -4.17 |
% Rank in Category | 67 | 57 | 62 | 20 | 16 | 26 | 31 | 40 |
Trailing Returns (GBP) | 18/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.71 | 0.15 | -0.40 |
1 Week | -3.33 | 0.93 | -1.01 |
1 Month | -4.29 | 1.60 | -0.08 |
3 Months | -2.70 | 0.41 | -6.55 |
6 Months | 4.13 | -3.01 | -4.62 |
YTD | -2.55 | 2.60 | -6.49 |
1 Year | -1.60 | 0.31 | -8.86 |
3 Years Annualised | 2.16 | 8.58 | -4.04 |
5 Years Annualised | 7.53 | 1.95 | -4.10 |
10 Years Annualised | 9.90 | 0.62 | -1.70 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.32 | - | - | - |
2023 | -4.18 | -1.22 | 0.00 | 6.80 |
2022 | -8.89 | -0.26 | 15.71 | -2.03 |
2021 | -6.46 | 7.79 | 5.06 | -3.38 |
2020 | 0.11 | 28.96 | -2.56 | 4.47 |
2019 | 15.85 | -0.22 | -9.29 | 12.68 |
|
Advertisement |